Genital Warts (HPV 6 & 11) Explained: Causes, Treatments, and Recurrence Rate — A Pharmacist's Guide
Figure 1: Genital warts (condyloma acuminata) clinical overview — understanding causes, medical treatments, recurrence rates, and the role of the HPV vaccine.
A few weeks ago, a close friend texted me out of nowhere.
"Hey. The doctor said I have genital warts."
Even through a screen, I could feel how deflated he was. Like the world had just ended.
Here's the thing, though — he's not uniquely unlucky. This is one of the most common viral infections in sexually active adults. Most people will encounter HPV at some point in their lives. He just happened to be diagnosed now.
I'm a licensed pharmacist with 9 years of experience, and I spent a good hour on the phone walking him through everything. Today, I'm writing it all down — plainly, honestly, without the scary jargon — so you can understand it too.
⚠️ Disclaimer: This article is for general educational purposes only and does not constitute medical advice, diagnosis, or treatment. If you are experiencing symptoms, please consult a licensed healthcare provider. The information here is based on guidelines from the NIH, BASHH (British Association for Sexual Health and HIV), and peer-reviewed academic literature.
What Are Genital Warts? Let's Start From the Beginning
The medical term is condyloma acuminata — but you don't need to remember that. Think of genital warts as the same kind of wart you'd get on your hand or foot, just located in the genital or anal area. Same viral family, different location.
The culprit is HPV (Human Papillomavirus). There are over 200 known types of HPV, but the ones responsible for genital warts are mainly types 6 and 11. Those two alone account for roughly 90% of all genital wart cases.
🤔 "Wait — isn't HPV the virus that causes cervical cancer?"
Partially true. HPV types 16 and 18 are the high-risk strains linked to cervical cancer. The types that cause genital warts (6 and 11) are considered low-risk — meaning they rarely, if ever, lead to cancer.
Think of them as cousins in the same viral family, but with very different personalities.
What Do Genital Warts Look Like — and Where Do They Appear?
They can look quite different from person to person, but here's what's typical:
- Flesh-colored or slightly pinkish bumps
- Usually 1–5 mm in size — about the size of a grain of rice or smaller
- Can be flat, raised, or have a cauliflower-like texture
- Often appear in clusters rather than as a single wart
In men, they tend to appear on the penis, scrotum, or around the anus. In women, common sites include the vulva, vagina, cervix, and perianal area. In rare cases, they can appear in the mouth or throat.
Here's what catches most people off guard: the majority of genital warts cause no pain, no itching, no bleeding. Many people don't even know they have them until a routine check-up. That's what makes HPV so easy to spread without realizing it.
How Do You Get It? And Is This Really That Common?
Genital warts spread primarily through skin-to-skin sexual contact. And here's the number that always surprises people:
HPV is the most common sexually transmitted infection in the world.
Research estimates that approximately 90% of sexually active men and 80% of women will be infected with HPV at some point in their lives. Getting HPV isn't a sign of recklessness or promiscuity — it's more like catching a cold. It happens.
That said, certain factors do increase your risk:
| Risk Factor | Why It Matters |
|---|---|
| Multiple partners | More exposure opportunities |
| Smoking | Lowers immunity; HPV persists longer |
| Weakened immunity | HIV, organ transplants, cancer treatment |
| History of other STIs | Prior chlamydia or gonorrhea raises susceptibility |
One thing that trips a lot of people up: HPV has an incubation period of 1 month to 2 years. That means if you just noticed warts, you may have been infected months or even over a year ago. There's no way to trace exactly who gave it to you, and asking that question often does more harm than good.
How Is It Treated — and Can It Be Cured?
This is where things get real. Let me be completely honest with you.
Your Treatment Options
There are two main approaches: in-office procedures and topical medications you apply at home.
| Treatment | How It Works | Notes |
|---|---|---|
| Laser / Electrosurgery | Destroys wart tissue with laser or electric current | ~100% clearance; in-office procedure |
| Cryotherapy | Freezes wart tissue with liquid nitrogen (-196°C) | Safe in pregnancy; multiple sessions often needed |
| Surgical Excision | Warts physically cut away by a clinician | Best for small, stem-like (pedunculated) warts |
| Podophyllotoxin | Self-applied at home; 3 days on / 4 days off, up to 4 weeks | Patient-applied; higher recurrence rate |
| Imiquimod (Aldara) | Applied 3x/week before sleep; rinsed off after 6–10 hours | Immune-stimulating; recurrence rate 6–26% |
| TCA Acid | Clinician-applied chemical; weekly sessions | Good for small or few warts; office visits required |
A Closer Look at Imiquimod (Aldara Cream)
Imiquimod — sold under the brand name Aldara — deserves its own explanation, because it works completely differently from everything else on that list.
Most treatments physically destroy the warts. Imiquimod doesn't. Instead, it wakes up your immune system and tells it to handle the virus itself.
Here's what's happening under the hood: imiquimod activates a receptor in your skin's immune cells called TLR-7 (Toll-like receptor 7 — think of it as an alarm switch on immune cells). Once triggered, it activates dendritic cells (your immune system's scout cells) and causes them to release interferon-alpha (a chemical messenger that signals an immune attack). The result is a targeted immune response against HPV-infected cells.
In plain English: imiquimod is basically your body receiving a memo that says "Hey — there's a virus here. Go deal with it."
That's why your skin gets red, itchy, and crusty after applying it. That's not a bad sign — it means your immune system is doing exactly what it's supposed to do.
Imiquimod: What the Clinical Data Shows
| Metric | Data |
|---|---|
| Complete clearance rate | 35–68% |
| Recurrence rate after clearance | 6–26% (lower than most other topical options) |
| How to use | 3x/week before sleep; wash off after 6–10 hours |
| Maximum duration | 16 weeks (safety beyond this not established) |
| Most common side effects | Itching (26%), burning (16%), redness (~61%) |
The 35–68% clearance rate might seem low compared to laser's near-100%. But that comparison misses the point. Laser removes the visible warts but leaves the virus behind. Imiquimod trains your immune system to suppress the virus — which is why the recurrence rate is significantly lower.
Key Things to Know If You're Using Imiquimod
- Avoid sexual contact while the cream is on your skin. It can transfer to your partner and may weaken latex condoms or diaphragms.
- Skin irritation is normal, but you can take breaks. If the redness or discomfort becomes severe, stop for a few days, let your skin recover, then resume. You don't have to push through.
- Each sachet is single-use only. Don't reuse an opened packet — discard it after each application.
- Not recommended during pregnancy. Safety data in pregnant women is limited. Use only under direct medical supervision.
- Not established for use in under-18s. Safety and efficacy in children and adolescents haven't been confirmed.
As a pharmacist: imiquimod is a slow burn, not a quick fix. The skin reaction you see isn't failure — it's the treatment working. Stopping early because it "doesn't feel like it's working" is one of the most common mistakes. Consistency matters far more than intensity.
So — Is There an Actual Cure?
Here's the honest answer:
"We can remove the visible warts. But there is currently no treatment that completely eliminates HPV from the body."
That means recurrence is possible after any treatment. Depending on the method, roughly 20–30% of people see warts return. Topical treatments tend to have higher recurrence rates than surgical options.
But don't let that number scare you — because that's not the whole story.
High Recurrence Rate — Does This Mean I Have to Live With This Forever?
This was the part my friend was most worried about. So I did the reading.
The short answer: no, not necessarily.
For most healthy adults, the immune system eventually gets the upper hand. Research shows that a significant portion of HPV infections clear on their own within 6 to 24 months. One cohort study in men found that the median time to viral clearance was just 7.5 months.
About 10% of people do develop persistent infections. But persistent infection doesn't automatically mean warts keep coming back forever — it just means the virus stays dormant longer.
This condition is better framed as something to manage rather than cure — much like how we think about cold sores or eczema.
How to Reduce Your Chances of Recurrence
- Quit smoking. Smoking is one of the clearest risk factors for HPV persistence and wart recurrence.
- Sleep and eat well. Your immune system is your main defense. Treat it accordingly.
- Show up for follow-ups, especially in the first 3–6 months. That window is when recurrence is most likely.
- Make sure your partner gets checked and treated too. Treating only one person in a couple leads to ping-pong reinfection.
Does HPV Only Affect Women? What About Men?
This is a common misconception worth correcting.
Most public awareness around HPV focuses on cervical cancer in women — and for good reason. But men are far from unaffected.
① Penile Cancer
High-risk HPV types (16 and 18) can transform cells in the penis and, over time, lead to penile cancer. The good news is that penile tissue is more resistant to malignant transformation than cervical tissue — but the risk isn't zero.
② Anal and Oropharyngeal Cancer
HPV is a known cause of anal cancer. Even more striking: recent data from the United States suggest that HPV-related oropharyngeal cancer (affecting the tonsils and base of the tongue) now occurs more frequently than cervical cancer. Oral HPV can be transmitted through oral sex.
③ Male Infertility
This one surprises most people. HPV infection in semen has been linked to reduced sperm motility and the formation of anti-sperm antibodies, which can contribute to infertility. Men with unexplained infertility have been found to have significantly higher rates of HPV infection than fertile controls.
The HPV vaccine isn't just for women. Men get real, tangible protection from it too.
What About My Partner? Is She at Risk for Cervical Cancer?
This is a legitimate concern, and it deserves a straight answer.
HPV types 6 and 11 — the ones causing genital warts — are low-risk and are not directly linked to cervical cancer. That's accurate.
But here's the catch: a person can carry both low-risk and high-risk HPV strains at the same time. Research suggests that roughly 30% of genital wart patients also carry high-risk HPV. If a high-risk strain is passed to a female partner, her cervical cancer risk increases.
A major study that followed over 70,000 women in Manchester, UK for 30 years found that HPV infection was associated with a steadily increasing risk of invasive cervical cancer for up to 30 years, reaching a cumulative risk of approximately 2.5%.
What a female partner should do:
- Get an HPV test and Pap smear (cervical cancer screening)
- Consider the Gardasil 9 vaccine if not yet vaccinated
- Keep up with regular cervical screening — especially if she tests HPV-positive, she should continue follow-up until the infection clears
I Already Have HPV — Is the Gardasil Vaccine Still Worth Getting?
Bottom line: yes, it's still worth it. But understand what it can and can't do.
The vaccine cannot treat an infection you already have. It can't clear warts that are already there. Think of it like a lock on a door — it can't help with burglars already inside, but it prevents new ones from getting in.
Gardasil 9 covers 9 HPV strains (6, 11, 16, 18, 31, 33, 45, 52, 58). Even if you have type 6, you're still unprotected against the other 8 strains — and the vaccine covers all of them.
There's also promising data on recurrence. One study found that women with a history of genital warts who were vaccinated had an average time-to-recurrence of 43.6 weeks, compared to just 16.4 weeks in unvaccinated women. The vaccine appears to help delay and reduce recurrence, even in people already infected.
Important: the vaccine is not a treatment. It won't shrink or remove existing warts. Its role is prevention and recurrence reduction — not cure.
Which Doctor Should I See?
Depends on your situation:
- Men: Urology, dermatology, or a sexual health clinic
- Women: Gynecology, dermatology, or a sexual health clinic
If you're unsure or embarrassed, you can call ahead and simply say you'd like to be seen for a genital wart or HPV concern. Most clinics handle this routinely and without judgment. Sexual health clinics in particular are set up specifically for this kind of visit.
Frequently Asked Questions
Q: Does using a condom prevent HPV?
Condoms reduce the risk significantly, but they don't eliminate it. HPV spreads through skin-to-skin contact, including areas not covered by a condom. That said, consistent condom use is still strongly recommended — it makes a real difference.
Q: Can I spread HPV even if I don't have visible warts?
Yes. HPV can be transmitted even when there are no visible symptoms. The virus lives on the skin and can be passed on during its dormant phase.
Q: Is one round of treatment enough?
Often not. Recurrence rates range from 20–30% with surgical methods, and higher with topical treatments. That doesn't mean the treatment failed — it's just how this virus behaves. Multiple rounds are common and normal.
Q: If I get married someday, will my spouse definitely get infected?
Not necessarily. When your immune system is actively suppressing the virus, transmission risk drops. Being open with your partner, getting them vaccinated, and keeping up with medical check-ups gives you both the best chance.
Q: Can I figure out who gave me HPV?
No. The incubation period can be up to two years, making it impossible to trace the source. Trying to figure it out usually causes more harm than good. Focus on what you can do now.
A Word From a Pharmacist
After I finished explaining everything, my friend let out a long breath and said: "So... I just have to manage it."
Exactly. That's all this is — management.
Genital warts are treatable. HPV is incredibly common. And for most people, the immune system eventually suppresses the virus on its own. The scariest part of this isn't the condition itself — it's the silence and shame that leads people to ignore it, hide it, and let it go untreated.
Having HPV doesn't make you a bad person. It makes you a human being who encountered an extremely common virus. See a doctor, have an honest conversation with your partner, and stay on top of your follow-ups. That's it. You can still live a completely normal life.
If you're reading this and going through something similar — you don't have to carry it alone. The more you know, the less it controls you.
References
Pennycook KB, McCready TA. Condyloma Acuminata. StatPearls. NIH National Library of Medicine, 2023. View source
Słowik M et al. The Condyloma acuminata — the review of the treatment methods. Journal of Education, Health and Sport, 2024. View source
Kore VB, Anjankar A. A Comprehensive Review of Treatment Approaches for Cutaneous and Genital Warts. Cureus, 2023. View source
Atlihan U et al. Evaluation of the Efficacy of AHCC as an Adjuvant in Reducing Recurrence After Condyloma Cauterization. MDPI, 2025. View source
Ong MM et al. HPV vaccine for the prevention and treatment of warts. JAAD Reviews, 2025. View source
Garolla A et al. HPV-related diseases in male patients: an underestimated conundrum. Journal of Endocrinological Investigation, 2024. View source
Iorga L et al. Penile carcinoma and HPV infection (Review). PMC / Experimental and Therapeutic Medicine, 2020. View source
Gilham C et al. Long-term risks of invasive cervical cancer following HPV infection. British Journal of Cancer, 2023. View source
Nugent D et al. BASHH National Guideline for the Management of Anogenital Warts in Adults. International Journal of STD & AIDS, 2024. View source
Comments
Post a Comment